"Drug Delivery Systems" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.
Descriptor ID |
D016503
|
MeSH Number(s) |
E02.319.300
|
Concept/Terms |
Drug Delivery Systems- Drug Delivery Systems
- Delivery System, Drug
- Delivery Systems, Drug
- Drug Delivery System
- System, Drug Delivery
- Systems, Drug Delivery
- Drug Targeting
- Drug Targetings
- Targeting, Drug
- Targetings, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Delivery Systems".
Below are MeSH descriptors whose meaning is more specific than "Drug Delivery Systems".
This graph shows the total number of publications written about "Drug Delivery Systems" by people in this website by year, and whether "Drug Delivery Systems" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
2001 | 0 | 1 | 1 |
2002 | 2 | 0 | 2 |
2003 | 3 | 2 | 5 |
2004 | 4 | 2 | 6 |
2005 | 3 | 2 | 5 |
2006 | 7 | 3 | 10 |
2007 | 7 | 4 | 11 |
2008 | 2 | 6 | 8 |
2009 | 8 | 6 | 14 |
2010 | 5 | 7 | 12 |
2011 | 4 | 3 | 7 |
2012 | 1 | 2 | 3 |
2013 | 4 | 0 | 4 |
2014 | 3 | 2 | 5 |
2015 | 1 | 3 | 4 |
2016 | 1 | 0 | 1 |
2017 | 5 | 3 | 8 |
2018 | 2 | 2 | 4 |
2019 | 4 | 2 | 6 |
2020 | 0 | 3 | 3 |
2021 | 2 | 1 | 3 |
2024 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Delivery Systems" by people in Profiles.
-
Celik B, Leal AF, Tomatsu S. Potential Targeting Mechanisms for Bone-Directed Therapies. Int J Mol Sci. 2024 Jul 30; 25(15).
-
Zhang SS, Li RQ, Chen Z, Wang XY, Dumont AS, Fan X. Immune cells: potential carriers or agents for drug delivery to the central nervous system. Mil Med Res. 2024 Mar 29; 11(1):19.
-
Sullivan MO, Chen W. Engineering Hepatitis B Virus (HBV) Protein Particles for Therapeutic Delivery. Methods Mol Biol. 2024; 2720:115-126.
-
Hinkle JW, Hsu J. THE RELATIONSHIP BETWEEN STOPPER POSITION AND INJECTION VOLUME IN RANIBIZUMAB AND AFLIBERCEPT PREFILLED SYRINGES. Retina. 2021 Dec 01; 41(12):2510-2514.
-
Holekamp NM, Campochiaro PA, Chang MA, Miller D, Pieramici D, Adamis AP, Brittain C, Evans E, Kaufman D, Maass KF, Patel S, Ranade S, Singh N, Barteselli G, Regillo C. Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology. 2022 03; 129(3):295-307.
-
Canseco JA, Karamian BA, Bowles DR, Markowitz MP, DiMaria SL, Semenza NC, Leibensperger MR, Smith ML, Vaccaro AR. Updated Review: The Steroid Controversy for Management of Spinal Cord Injury. World Neurosurg. 2021 06; 150:1-8.
-
Sawamoto K, ?lvarez JV, Herre?o AM, Otero-Espinar FJ, Couce ML, Alm?ciga-D?az CJ, Tomatsu S. Bone-Specific Drug Delivery for Osteoporosis and Rare Skeletal Disorders. Curr Osteoporos Rep. 2020 10; 18(5):515-525.
-
Kimchi N, Bielory L. The allergic eye: recommendations about pharmacotherapy and recent therapeutic agents. Curr Opin Allergy Clin Immunol. 2020 08; 20(4):414-420.
-
Shalaby WS, Shankar V, Razeghinejad R, Katz LJ. Current and new pharmacotherapeutic approaches for glaucoma. Expert Opin Pharmacother. 2020 Nov; 21(16):2027-2040.
-
Guerra K, Bryan C, Dapaah-Siakwan F, Sammour I, Drummond S, Zambrano R, Chen P, Huang J, Sharma M, Shrager S, Benny M, Wu S, Young KC. Intra-tracheal administration of a naked plasmid expressing stromal derived factor-1 improves lung structure in rodents with experimental bronchopulmonary dysplasia. Respir Res. 2019 Nov 12; 20(1):255.